Active-ingredient Dossier
Teriflunomide
Active-ingredient Dossier for Teriflunomide (immunosuppressive agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: TERIFLUNOMIDE
- Brand: TERIFLUNOMIDE-AX
- Brand: APO-TERIFLUNOMIDE
- Brand: Teri-EM
- Brand: TERIFLAGIO
- Brand: TERIFLUNOMIDE
- Therapeutic area: Neurology
What is
Teriflunomide Teriflunomide is an immunosuppressive agent.
Australian brands containing
Teriflunomide — TERIFLUNOMIDE — TERIFLUNOMIDE-AX — APO-TERIFLUNOMIDE — Teri-EM — TERIFLAGIO — TERIMIDE — APX-TERIFLUNOMIDE — AUBAGIO — TERIBIC
Therapeutic areas
Teriflunomide is registered in neurology (14 brands) and complementary medicine (1 brand).
Sponsor landscape
Teriflunomide is marketed by Dr Reddys Laboratories, Arrotex Pharmaceuticals, Alembic Pharmaceuticals, Sanofi-Aventis, Emcure Pharmaceuticals, and Sandoz.
PBS and regulatory activity
One brand containing teriflunomide has a PBS-listed item, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2016, and no AusPARs have been recorded.